auditoria
de
lo
pacient
hospitalizado
por
de
epoc
en
estudio
audipoc
del
trabajo
factor
asociado
con
el
control
del
asma
en
pacient
de
primaria
en
el
estudio
cha
valor
pretratamiento
e
inducido
por
el
tratamiento
de
enolasa
de
neurona
en
pacient
con
de
estudio
prospectivo
abierto
del
test
de
control
del
asma
act
con
la
pulmonar
nivel
de
exhalado
grado
de
control
la
iniciativa
global
para
el
asma
gina
mani
asthma
exacerb
caus
respiratori
viral
infect
induc
interplay
immun
respons
howev
time
trend
immun
respons
phenomena
well
studi
object
identifi
possibl
mechan
underli
link
respiratori
viral
infect
asthma
exacerb
patient
method
recruit
adult
age
year
group
healthi
b
healthi
viral
infect
c
mild
moder
asthma
c
viral
infect
cytokin
induc
sputum
sampl
cours
acut
upper
respiratori
viral
infect
otherwis
healthi
asthmat
individu
monitor
assay
elisa
viral
infect
symptom
asthma
sever
score
monitor
time
trend
analyz
use
linear
mix
model
result
level
group
c
higher
group
b
level
viral
infect
symptom
score
group
b
spike
day
rapidli
declin
day
group
symptom
score
viral
infect
asthma
peak
much
later
day
slowli
declin
ratio
group
significantli
higher
group
c
conclus
infectioninduc
asthma
exacerb
may
due
impair
antivir
respons
appear
critic
window
day
therapeut
intervent
separ
publish
elsevi
sl
right
reserv
fundamento
mucha
de
la
exacerbacion
del
asma
se
deben
infeccion
de
la
respiratoria
que
inducen
una
de
respuesta
inmunitaria
entr
sin
embargo
la
tendencia
temporal
de
esta
respuesta
durant
esto
se
han
estudiado
con
detal
objetivo
identificar
lo
posibl
mecanismo
subyacent
de
la
entr
la
infeccion
respiratoria
la
exacerbacion
del
asma
pacient
seleccionamo
adulto
de
de
edad
en
grupo
sano
b
sano
con
c
con
asma
leve
moderada
igual
que
c
pero
con
durant
el
curso
de
una
aguda
de
la
respiratoria
superior
se
monitorizaron
la
citocina
en
muestra
de
esputo
inducido
en
individuo
por
lo
sano
en
pacient
la
interleucina
il
la
el
gamma
se
analizaron
mediant
un
elisa
se
monitorizaron
la
puntuacion
de
lo
de
de
gravedad
del
asma
la
tendencia
temporal
se
analizaron
mediant
la
de
modelo
mixto
lineal
asthma
seriou
public
health
concern
global
initi
asthma
gina
report
worldwid
million
individu
suffer
asthma
load
aggrav
fact
mani
asthmat
patient
suffer
exacerb
symptom
due
extern
caus
relat
underli
diseas
prospect
studi
shown
exacerb
children
half
adult
due
viral
infect
accord
clinic
observ
frequent
asthma
exacerb
take
place
day
individu
contract
viral
infect
upper
airway
current
studi
aim
determin
possibl
mechan
causal
relationship
viral
infect
asthma
exacerb
focus
interact
immun
respons
group
helper
lymphocyt
differenti
cytokin
releas
cell
predominantli
produc
gamma
interferon
cell
produc
interleukin
il
healthi
individu
homeostasi
import
chang
th
popul
th
cell
replac
cell
tend
decreas
product
cell
wherea
increas
cell
suppress
product
cell
viral
airway
infect
predomin
type
immun
respons
modul
deviat
immun
system
toward
respons
present
asthma
fact
immun
statu
establish
asthma
may
alter
cours
antivir
respons
consid
inhibit
product
effect
asthma
treatment
furthermor
although
use
strategi
eosinophilia
suppress
shown
use
clinic
point
view
lack
efficaci
administr
suppress
activ
also
report
one
problem
determin
optimum
treatment
modal
time
trend
immun
respons
studi
detail
acut
viral
infect
among
variou
noninvas
method
assess
airway
inflamm
induc
sputum
examin
rel
simpl
strategi
freez
induc
sputum
sampl
immedi
collect
subsequ
process
conveni
laboratori
technician
prevent
problem
caus
enzym
content
bodi
fluid
digest
fluid
cell
compon
sampl
frozen
differ
research
team
test
techniqu
last
year
studi
use
method
assess
time
depend
chang
cytokin
cytokin
induc
sputum
sampl
asthmat
patient
healthi
control
individu
without
airway
viral
infect
aim
studi
establish
antivir
airway
immun
respons
pattern
absenc
presenc
asthmat
immun
respons
identifi
possibl
mechan
relationship
viral
airway
infect
asthma
exacerb
base
research
committe
huashan
hospit
affili
fudan
univers
approv
studi
individu
provid
written
inform
consent
take
part
studi
select
total
adult
year
old
men
women
distribut
group
per
group
base
airway
health
statu
group
includ
healthi
individu
group
b
includ
individu
viral
infect
upper
airway
otherwis
healthi
group
c
includ
individu
control
mild
moder
asthma
group
includ
individu
control
mild
moder
asthma
viral
infect
upper
airway
group
exclus
criteria
follow
histori
sever
cardiopathi
hypertens
chronic
bronchiti
glaucoma
prostat
hypertrophi
thyroid
condit
diabet
anaemia
liver
renal
failur
pregnant
lactat
women
also
exclud
inclusionexclus
criteria
group
follow
group
b
individu
histori
allerg
immunolog
diseas
receiv
viral
vaccin
last
month
taken
part
clinic
drug
trial
last
month
group
b
individu
diagnosi
acut
viral
infect
upper
airway
base
sign
symptom
systemat
laboratori
test
exam
viral
detect
includ
group
b
individu
suspect
bacteri
infect
base
sign
symptom
laboratori
test
exclud
exampl
wbc
count
minimum
l
percentag
neutrophil
minimum
greater
refer
valu
chest
xray
indic
pneumonia
includ
viral
pneumonia
individu
group
b
personnel
huashan
hospit
affili
fudan
univers
shanghai
china
group
c
asthmat
ambulatori
patient
monitor
huashan
hospit
affili
fudan
univers
patient
diagnos
asthma
base
criteria
develop
chines
societi
respiratori
diseas
classifi
mild
moder
patient
receiv
regular
treatment
accord
gina
guidelin
treat
inhal
budesonid
turbuhal
mainten
treatment
remiss
patient
group
c
receiv
viral
vaccin
last
month
taken
part
clinic
drug
trial
previou
month
patient
group
b
diagnosi
acut
viral
infect
upper
airway
made
base
sign
symptom
systemat
laboratori
test
viru
detect
patient
group
exclud
bacteri
infect
suspect
base
sign
symptom
laboratori
test
patient
group
also
exclud
symptom
becam
deterior
upper
airway
infect
sputum
induct
could
achiev
individu
told
go
hospit
hour
soon
experi
sign
upper
airway
viral
infect
resultado
en
lo
grupo
c
lo
valor
de
e
fueron
mayor
que
en
lo
grupo
b
en
el
grupo
b
lo
valor
de
la
puntuacion
de
de
fueron
en
el
disminuyeron
en
el
mientra
que
en
el
grupo
lo
valor
de
la
puntuacion
de
de
de
asma
alcanzaron
un
mucho
tard
disminuyeron
lentament
en
el
grupo
lo
cocient
e
fueron
significativament
alto
que
en
el
grupo
c
conclusion
la
exacerbacion
del
asma
inducida
por
la
infeccion
pueden
debers
un
deterioro
de
la
respuesta
inmunitaria
parec
identificars
un
intervalo
decisivo
de
para
instaurar
una
separ
publicado
por
elsevi
sl
todo
lo
derecho
reservado
agre
undergo
systemat
laboratori
test
chest
xray
individu
follow
day
sputum
induc
daili
score
upper
airway
viral
infect
symptom
asthma
regist
daili
clinic
featur
patient
caught
cold
fever
chill
sweat
discomfort
pharyng
rhiniti
nasal
congest
sneez
headach
malais
joint
pain
physic
examin
indic
erythema
pharyng
inflamm
lung
auscult
detect
dri
humid
crackl
laboratori
test
systemat
haemogram
wbc
count
l
neutrophil
higher
baselin
imag
chest
xray
show
lung
condens
sign
infect
old
lesion
exclud
symptom
viral
airway
infect
score
follow
way
mild
moder
sever
tabl
includ
criteria
use
assign
score
diagnosi
degre
treatment
asthma
carri
accord
gina
criteria
tabl
show
criteria
use
assign
symptom
score
asthma
sputum
induc
daili
day
accord
previous
describ
summaris
basal
spirometri
pretreat
salbutamol
individu
inhal
hyperton
salin
solut
minut
period
period
tri
expector
sputum
plastic
contain
sputum
sampl
pour
petri
plate
immedi
induct
mucu
plug
lower
airway
chosen
put
eppendorf
tube
ml
dimethyl
sulfoxid
ad
merck
germani
tube
hermet
close
stir
code
store
freezer
dayshift
laboratori
assist
process
frozen
sputum
sampl
use
previous
describ
protocol
slight
modif
eppendorf
tube
thaw
room
temperatur
content
weigh
volum
dithiothreitol
solut
sputolysin
calbiochem
corp
la
jolla
california
usa
dilut
distil
water
equal
time
weight
sputum
mg
homogenis
use
mixer
tube
place
rock
platform
shaker
volum
buffer
dulbecco
salin
phosphat
ad
equival
dithiothreitol
solut
use
suspens
filter
use
gauz
cell
viabil
assess
exclus
trypan
blue
cell
suspens
centrifug
supernat
frozen
subsequ
detect
first
day
first
viral
infect
symptom
elisa
equip
simcer
nanj
china
use
detect
airway
virus
accord
manufactur
instruct
viral
spectrum
identifi
equip
rhinoviru
syncyti
airway
viru
flu
viru
parainfluenza
adenoviru
coronaviru
virus
concentr
supernat
determin
use
elisa
rapid
biolab
calabasa
ca
usa
equip
result
express
pgml
due
reduc
size
sampl
nonparametr
kruskalw
test
use
compar
group
mean
standard
deviat
determin
age
haematolog
test
index
distribut
gender
number
percentag
compar
use
fisher
exact
test
cytokin
measur
repeat
test
day
linear
mix
model
use
test
time
trend
compar
group
mean
standard
deviat
calcul
cytokin
ratio
time
trend
group
effect
statist
signific
posthoc
analysi
tukey
test
perform
statist
signific
establish
valu
p
statist
analysi
statist
program
spss
version
spss
inc
chicago
usa
use
select
total
adult
year
old
men
women
describ
method
diffus
bilater
pulmonari
sibil
distribut
group
b
c
base
airway
health
statu
group
tabl
includ
summari
baselin
characterist
compar
group
signific
differ
found
term
age
gender
basophil
percentag
platelet
count
rbc
count
haemoglobin
valu
furthermor
signific
differ
found
group
regard
wbc
count
wbc
formula
patient
upper
airway
infect
group
b
higher
wbc
count
increas
percentag
eosinophil
lymphocyt
monocyt
lower
percentag
neutrophil
healthi
individu
group
patient
asthma
group
c
detect
detect
viru
induc
sputum
sampl
elisa
equip
use
expect
group
c
sampl
viru
detect
group
signific
chang
detect
p
regard
fig
group
c
group
report
higher
valu
observ
group
day
although
differ
group
c
disappear
day
valu
group
c
chang
significantli
time
p
wherea
valu
group
b
increas
significantli
day
chang
day
sic
decreas
day
p
group
b
p
group
fig
group
c
lower
valu
group
day
similar
valu
day
initi
lower
valu
found
group
group
day
howev
group
valu
higher
group
day
although
differ
day
statist
signific
group
c
valu
vari
significantli
observ
period
p
interest
highlight
valu
group
b
reach
maximum
day
afterward
decreas
rapidli
day
valu
similar
day
howev
maximum
valu
group
identifi
day
decreas
day
concentr
pgml
similar
valu
observ
day
also
calcul
ratio
cytokin
daili
result
ratio
figur
tabl
group
logic
significantli
lower
group
c
p
regard
time
trend
signific
variat
detect
ratio
group
b
p
group
although
time
trend
differ
group
b
ratio
day
later
significantli
greater
valu
detect
day
previous
p
ratio
decreas
slightli
day
afterward
increas
significantli
form
day
wherea
day
similar
day
p
group
ratio
increas
significantli
day
p
day
ratio
significantli
higher
day
day
significantli
differ
valu
seen
day
p
symptom
score
airway
viral
infect
tabl
asthma
symptom
tabl
regist
daili
individu
group
b
c
accordingli
tabl
includ
daili
result
score
asthma
score
group
score
day
similar
group
c
howev
asthma
score
increas
group
day
reach
maximum
day
p
compar
group
c
group
report
higher
score
asthma
symptom
day
p
group
asthma
symptom
score
day
similar
upper
airway
symptom
score
similar
score
group
b
identifi
day
afterward
score
group
b
significantli
lower
group
maximum
score
group
b
regist
day
decreas
rapidli
day
p
score
group
increas
rapidli
day
decreas
day
p
score
regist
day
similar
day
studi
order
better
understand
complex
interact
viral
infect
asthma
continu
tabl
baselin
characterist
group
n
group
b
n
group
c
n
group
n
mean
sd
mean
sd
mean
sd
mean
sd
valu
p
monitor
concentr
cytokin
induc
sputum
sampl
asthmat
patient
healthi
individu
control
group
without
viral
airway
infect
regist
score
asthma
upper
airway
viral
infect
symptom
period
observ
individu
present
low
valu
induc
sputum
bare
fluctuat
day
level
sputum
increas
rapidli
day
high
valu
patient
contract
viral
infect
upper
airway
also
found
viral
infect
symptom
show
earli
stage
remit
fast
show
healthi
individu
effect
antivir
immun
induc
sputum
valu
neg
correl
symptom
observ
previou
studi
found
individu
asthma
even
remiss
stage
present
higher
valu
e
lower
valu
healthi
individu
higher
ratio
p
result
confirm
asthmat
individu
histori
immun
system
deviat
toward
respons
consist
data
research
anim
clinic
set
furthermor
acut
exacerb
asthma
predomin
th
evid
recent
test
indic
abnorm
deviat
toward
activ
asthmat
patient
could
relat
decreas
function
type
th
cell
ie
regul
cell
cell
seem
reduc
activ
healthi
individu
popul
natur
aggressor
cell
could
also
play
role
asthma
pathogenesi
valu
induc
sputum
patient
asthma
even
remiss
increas
lower
degre
slowli
nonasthmat
individu
asthmat
individu
also
higher
viral
infect
symptom
score
healthi
individu
argu
asthmat
patient
vulner
viral
airway
infect
patient
asthma
even
though
may
suffer
seriou
consequ
indic
possibl
may
suffer
deterior
antivir
respons
consequ
develop
prolong
infect
caus
sever
airway
obstruct
wheez
interest
highlight
product
respons
airway
virus
could
also
impair
evid
prove
insuffici
product
airway
asthmat
patient
caus
viral
infect
epitheli
cell
infect
cell
show
ineffici
apoptot
respons
consequ
viru
rapidli
multipli
cell
enter
airway
viral
load
much
higher
healthi
patient
furthermor
viru
induc
secret
posit
relat
lung
function
asthmat
individu
global
find
indic
deterior
ifn
respons
could
lead
seriou
clinic
featur
viral
airway
infect
patient
suffer
asthma
also
found
symptom
score
asthmat
patient
much
higher
asthmat
patient
without
upper
airway
viral
infect
find
consist
like
exacerb
phenotyp
howev
find
signific
differ
ratio
healthi
individu
without
tabl
variat
ratio
one
week
group
n
group
b
n
group
c
n
group
n
mean
sd
mean
sd
mean
sd
mean
sd
valu
p
upper
airway
viral
infect
indic
signific
chang
homeostasi
furthermor
observ
signific
differ
ratio
asthmat
individu
without
upper
airway
viral
infect
indic
probabl
mechan
regul
homeostasi
recent
cours
clinic
studi
much
attent
given
regul
lymphocyt
found
regul
homeostasi
number
mechan
studi
determin
time
trend
chang
induc
sputum
patient
asthma
airway
viral
infect
consist
fluctuat
asthma
symptom
sinc
seriou
day
contract
infect
result
conclud
day
contract
viral
infect
upper
airway
timefram
infect
symptom
worsen
patient
asthma
possibl
recommend
administ
treatment
soon
possibl
timefram
balanc
immun
respons
inclin
toward
cell
patient
mild
moder
asthma
even
remiss
antivir
immun
airway
less
resist
patient
weaker
compar
antivir
immun
healthi
individu
asthmat
patient
viral
infect
induc
cell
respons
upper
airway
exacerb
imbal
indic
exist
mechan
control
balanc
found
timefram
infect
symptom
begin
worsen
patient
asthma
day
contract
infect
airway
viral
infect
otherwis
healthi
group
c
mild
moder
asthma
group
group
c
airway
viral
infect
n
per
group
result
mean
standard
deviat
linear
mix
method
use
analys
time
trend
signific
time
trend
found
tukey
test
use
posthoc
analysi
legend
pgml
time
day
group
group
b
group
c
group
pgml
time
day
group
group
b
group
c
group
interferon
gamma
pg
ml
time
day
group
group
b
group
c
group
